Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

510 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 413 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 81.9M shares of 106M outstanding shares and own 77.51% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.8M shares), BlackRock Inc. (5.96M shares), JANUS HENDERSON GROUP PLC (4.89M shares), Capital International Investors (4.82M shares), Avoro Capital Advisors LLC (4.34M shares), WELLINGTON MANAGEMENT GROUP LLP (3.25M shares), FARALLON CAPITAL MANAGEMENT LLC (2.45M shares), STATE STREET CORP (2.12M shares), Bank of New York Mellon Corp (2.07M shares), and T. Rowe Price Investment Management, Inc. (1.93M shares).
This table shows the top 413 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.